pathogen
identif
crucial
first
defens
bioterror
major
emphasi
nation
biodefens
strategi
establish
fast
accur
sensit
assay
diagnosi
infecti
diseas
agent
like
use
bioterrorist
event
center
diseas
control
prevent
nation
institut
health
nation
institut
allergi
infecti
diseas
identifi
three
prioriti
class
select
agent
pathogen
toxin
design
b
c
like
candid
sinc
easili
dissemin
usual
aerosol
form
requir
small
number
organ
molecul
caus
diseas
result
rapid
morbid
mortal
challeng
infecti
diseas
specialist
agent
rare
encount
normal
practic
mani
seen
remot
outbreak
distant
countri
one
smallpox
erad
last
case
observ
sever
decad
ago
first
line
defens
vast
major
physician
may
abl
distinguish
earli
event
bioterrorist
event
atyp
pneumonia
cutan
infect
challeng
rapid
pathogen
toxin
recognit
aid
physician
diagnost
process
help
identifi
earli
stage
potenti
deliber
outbreak
assay
ensur
earli
appropri
treatment
infect
patient
alert
public
health
author
law
enforc
help
contain
outbreak
major
lesson
octob
anthrax
outbreak
aggress
therapeut
intervent
save
live
sinc
highli
virul
organ
like
anthrax
respond
well
antimicrobi
therapi
diagnos
earli
stage
unfortun
earli
sign
symptom
mani
diseas
nonspecif
critic
highli
sensit
reliabl
tool
avail
identifi
infect
individu
first
step
toward
effect
patient
public
health
control
identifi
rapidli
infect
pathogen
sourc
select
agent
highli
transmiss
earli
stage
diseas
critic
identifi
infect
patient
limit
risk
remaind
popul
case
hemorrhag
fever
ebola
viru
hypothes
patient
becom
infect
contact
infect
anim
yet
natur
reservoir
viru
unknown
manner
viru
first
appear
human
start
outbreak
whether
initi
sourc
elucid
rapid
diagnost
procedur
critic
support
infect
control
measur
monitor
limit
spread
infecti
diseas
agent
final
accur
defin
scope
progress
infecti
diseas
outbreak
help
mobil
resourc
effici
eas
public
anxieti
lead
panic
rapid
clinic
diagnosi
aggress
preemptiv
therapi
limit
fatal
associ
biolog
agent
mass
destruct
clinic
laboratori
howev
still
reli
upon
culturebas
technolog
phenotyp
endpoint
approv
fda
andor
cdc
assay
take
sever
day
definit
result
addit
time
delay
techniqu
often
lack
adequ
sensit
specif
organ
difficult
isol
cultur
delay
often
translat
initi
empir
therapi
absenc
posit
pathogen
identif
problem
limit
bioterror
outbreak
hospit
public
health
laboratori
confound
inadequ
slow
methodolog
pathogen
detect
often
difficulti
identifi
pathogen
occur
ill
andor
immunocompromis
patient
delay
increas
morbid
mortal
bioterrorist
event
like
mani
natur
occur
diseas
outbreak
need
obtain
rapid
pathogen
identif
clinic
specimen
also
environment
specimen
minim
fomitebas
transmiss
time
delay
measur
day
prevent
adequ
public
health
measur
institut
contain
outbreak
delay
also
subject
expos
individu
needless
stress
anxieti
inadequaci
phenotypicbas
diagnost
assay
illustr
graphic
gold
standard
public
health
laboratorytest
algorithm
place
posit
identif
bacillu
anthraci
environment
sampl
octob
anthrax
outbreak
fig
complic
matrix
phenotyp
biochem
assay
requir
day
posit
endpoint
need
streamlin
approach
could
progress
primari
specimen
posit
neg
outcom
matter
hour
less
fig
rapid
diagnost
final
come
age
offer
except
promis
regard
accur
pathogen
identif
serolog
techniqu
invalu
detect
activ
infect
organ
difficult
cultur
document
previou
infectionimmun
convent
serodiagnosi
limit
abil
detect
acut
infect
select
agent
invalu
monitor
diseas
kinet
dispers
agent
within
expos
highrisk
popul
especi
asymptomat
infect
frequent
inform
crucial
therapeut
intervent
prophylaxi
well
isol
protocol
context
biolog
attack
serodiagnosi
particularli
use
mass
screen
infecti
diseas
techniqu
gener
simpl
perform
inexpens
amen
high
throughput
technolog
assay
take
advantag
exquisit
sensit
specif
antigenantibodi
interact
antigen
captur
assay
repres
somewhat
recent
addit
serolog
techniqu
method
use
rapidli
diagnos
acut
infect
antigen
level
rel
high
especi
urin
may
concentr
enzym
link
immunosorb
assay
elisa
becom
workhors
clinic
laboratori
reli
specif
antigenantibodi
interact
identifi
pathogen
typic
preliminari
test
perform
quickli
usual
within
h
posit
elisa
test
confirm
perform
western
blot
targetspecif
antibodi
immunofluoresc
antibodi
ifa
unfortun
pathogen
antigen
product
host
antibodi
respons
alway
robust
enough
permit
reliabl
test
especi
earli
stage
infect
addit
fals
posit
result
elisa
test
occur
due
interfer
antibodi
although
elisa
test
highli
specif
antibodi
respons
may
detect
either
earli
late
stage
diseas
improv
sensit
may
obtain
expand
class
antibodi
detect
igg
iga
andor
igm
class
antibodi
elisa
platform
especi
well
suit
toxin
detect
combin
procedur
timeresolv
fluorometri
sensit
pgml
obtain
typic
h
assay
molecul
botulinum
type
b
neurotoxin
staphylococcu
aureu
enterotoxin
b
newer
format
antigenantibodi
detect
detector
antibodi
label
chemiluminesc
facilit
even
greater
sensit
one
approach
target
antigen
first
complex
paramagnet
bead
coat
captur
antibodi
identifi
use
detector
antibodi
electrochem
flow
cell
photon
detector
use
detect
targetantibodi
interact
detect
limit
approach
fmoll
dynam
rang
six
order
magnitud
recent
novel
type
biosensor
rapid
pathogen
identif
describ
use
b
cell
sens
element
system
know
canari
cellular
analysi
notif
antigen
risk
yield
util
b
lymphocyt
genet
engin
express
cytosol
aquorin
calciumsensit
bioluminesc
protein
membran
bound
antibodi
specif
given
pathogen
toxin
interact
antigen
antibodi
elev
intracellular
calcium
level
result
light
emiss
cytosol
aquorin
molecul
system
respond
fashion
rapid
sensit
specif
antigen
detect
system
shown
detect
yersinia
pesti
less
min
level
coloni
form
unit
recent
year
recognit
pathogen
evok
specif
tcell
respons
use
develop
assay
use
enzymelink
immunospot
assay
elispot
tspot
quantiferontb
diagnosi
latent
tuberculosi
infect
exquisit
sensit
assay
signatur
tb
peptid
elicit
specif
interferon
gamma
releas
make
applic
immunosuppress
individu
specif
assay
overcom
problem
prior
vaccin
bacil
bcg
assay
distinguish
drug
sensit
resist
form
tb
particularli
valuabl
follow
diseas
transmiss
set
multidrug
resist
mdr
extrem
drug
resist
xdr
strain
preval
enzymat
activ
use
time
detect
microorgan
exampl
presenc
signific
level
helicobact
pylori
gastric
secret
made
use
detect
ureas
activ
bacillu
although
bacteri
ureas
product
uniqu
h
pylori
urea
produc
found
human
stomach
site
replic
h
pylori
exampl
bioterror
antigen
detect
system
util
specif
enzymat
interact
substrat
rather
bind
antibodi
micromechanosensor
report
liu
et
al
function
natur
toxin
detect
util
microfabr
cantilev
proof
concept
model
botulinum
neurotoxin
b
detect
activ
endopeptidas
cleav
neurotarget
synaptobrevin
also
refer
vamp
report
system
detect
larg
chang
reson
frequenc
vibrat
cantilev
follow
releas
agaros
bead
bound
cantilev
synaptobrevin
cantalev
system
sensit
gaseou
vacuum
milieu
fluid
medium
damp
vibrat
degre
detect
botulinum
toxin
nm
concentr
within
min
applic
onchip
electron
technolog
greatli
increas
sensit
effect
diagnost
assay
must
rapid
sensit
specif
well
simpl
robust
facilit
use
clinic
public
health
laboratori
assay
detect
wide
varieti
pathogen
possibl
capac
detect
design
organ
heterolog
express
toxin
virul
gene
creat
recombin
technolog
geneticbas
molecular
assay
current
develop
includ
categori
c
pathogen
toxin
gene
also
includ
wide
rang
common
bacteria
virus
fungi
approach
possibl
recogn
clinic
respiratori
secret
blood
urin
tissu
environment
includ
letter
nasal
swab
hair
food
water
sampl
presenc
pathogen
organ
present
homogen
popul
cloak
dispers
within
larg
popul
nonpathogen
organ
also
possibl
detect
unnatur
event
express
lethal
toxin
gene
botulinum
toxin
gene
recipi
nonpathogen
organ
escherichia
coli
bacillu
subtili
similarli
mix
powder
contain
anthraxladen
spore
background
b
subtili
spore
would
perceiv
harmless
b
anthraci
compon
began
caus
diseas
complex
mixtur
easili
resolv
molecular
diagnost
specif
sensit
also
key
element
diagnost
assay
specif
probe
use
must
shown
interact
design
target
avoid
fals
posit
respons
advent
realtim
selfreport
probe
capabl
allelespecif
sequenc
discrimin
level
singl
nucleotid
allow
probe
react
except
fidel
sensit
major
requir
especi
earli
stage
diseas
pathogen
may
present
detect
pathogen
like
francisella
tularensi
etiolog
agent
tularemia
need
organ
caus
lethal
diseas
microarray
nucleic
acid
develop
util
enorm
amount
inform
provid
genom
project
clear
potenti
mass
screen
diagnost
microarray
allow
thousand
target
analyz
simultan
particularli
use
novel
viru
identif
character
microarray
consist
gene
genomespecif
nucleic
acid
fragment
either
clone
gene
segment
long
mer
oligonucleotid
fix
glass
slide
solid
matrix
use
comput
chip
one
product
high
densiti
oligonucleotidebas
dna
array
develop
affymetrix
target
dna
rna
label
hybrid
complementari
dna
sequenc
microarray
scan
laser
use
detect
high
affin
interact
address
posit
correspond
known
target
applic
matur
technolog
may
best
illustr
outbreak
sar
earli
assist
tri
ident
pathogen
cdc
refer
specimen
contain
unknown
agent
mani
laboratori
includ
dr
joseph
derisi
derisi
develop
microarray
chip
call
virochip
contain
nucleic
acid
specif
numer
virus
known
caus
human
diseas
hybrid
unknown
viru
genom
segment
chip
reveal
presenc
previous
uncharacter
coronaviru
subsequ
molecular
character
phylogenet
sequenc
comparison
confirm
viru
new
member
famili
microarray
technolog
power
also
expens
technic
demand
labor
intens
amplifi
sampl
background
critic
achiev
depend
result
highli
purifi
nucleic
acid
sampl
best
assay
interf
substanc
may
limit
hybrid
fals
posit
interact
usual
minim
care
microarray
develop
suitabl
redund
target
best
howev
verifi
independ
posit
hit
differ
techniqu
like
hybridizationbas
assay
target
specif
critic
although
absolut
fidel
fine
tune
allelespecif
level
singl
nucleotid
chang
desir
subtyp
speci
abil
detect
imperfect
match
within
famili
equal
desir
discoveri
new
diseas
agent
variant
old
one
sar
cov
cours
genet
microarray
like
genet
approach
detect
presenc
toxin
gene
use
directli
detect
toxin
trend
toward
fulli
autom
microfluid
applic
involv
chipbas
capillari
electrophoresi
perform
inlin
reagent
dispens
hybrid
detect
significantli
reduc
sampl
size
improv
accuraci
combin
array
hybrid
follow
direct
viral
sequenc
recoveri
provid
gener
strategi
rapid
identif
character
novel
virus
emerg
infecti
diseas
abil
dna
microarray
identifi
either
multipl
gene
target
singl
multipl
pathogen
singl
sampl
capac
transform
detect
emerg
pathogen
particularli
use
evalu
rapidli
chang
diseas
agent
influenza
new
platform
greenechippm
panmicrobi
microarray
compris
sixtym
oligonucleotid
suitabl
comprehens
detect
wide
rang
vertebr
virus
bacteria
fungi
parasit
technolog
potenti
transform
blood
test
provid
integr
platform
comprehens
test
replac
multipl
individu
assay
simplest
pcr
form
involv
use
specif
primer
amplifi
known
target
fragment
dna
rna
detect
product
intercal
dye
approach
reli
upon
specif
linear
dnadna
dnarna
hybrid
probe
amplif
process
probetarget
hybrid
highli
temperatur
depend
howev
depend
nucleotid
composit
probe
random
anneal
pose
problem
sequenc
high
g
c
content
especi
vulner
sinc
temperatur
profil
anneal
shift
fals
prime
may
occur
gener
standard
pcrbase
amplif
insuffici
identif
purpos
due
rel
high
level
fals
posit
result
solut
problem
use
fluoresc
probe
endonucleas
adjac
linear
hairpin
oligoprob
selffluoresc
amplicon
requir
high
fidel
bind
target
sequenc
detect
high
fidel
probe
especi
selfreport
probe
addit
advantag
pcr
amplif
detect
done
seal
tube
greatli
reduc
possibl
contamin
also
use
realtim
assay
product
format
continu
monitor
valid
import
consider
clinic
microbiolog
lab
pcr
amplif
potenti
amplifi
small
amount
target
dna
contamin
organ
even
human
dna
realtim
pcr
requir
postpcr
sampl
handl
prevent
potenti
pcr
product
carryov
contamin
facilit
high
throughput
assay
realtim
pcr
assay
use
high
fidel
probe
also
rapid
h
quantit
larg
dynam
rang
exceed
millionfold
start
target
probe
system
includ
lightcyclertm
taqmantm
molecular
beacon
wide
use
identifi
pathogen
realtim
assay
lightcycl
system
measur
fluoresc
reson
energi
transfer
fret
two
linear
oligonucleotid
probe
label
differ
fluorophor
glass
capillari
tube
format
probe
hybrid
target
headtotail
motif
anneal
stage
pcr
bring
fluorophor
close
proxim
caus
transfer
energi
result
emiss
detect
fluoresc
light
taqman
probe
linear
oligonucleotid
contain
report
dye
acceptor
overlap
emissionabsorpt
spectra
report
dye
remain
quench
acceptor
hybrid
target
cleavag
report
nucleas
activ
taq
dna
polymeras
result
strong
fluoresc
signal
taqman
util
well
format
amen
high
throughput
screen
one
limit
fretbas
system
multiplex
limit
sinc
sever
quencher
reaction
requir
spectral
overlap
problem
molecular
beacon
small
singl
strand
nucleic
acid
hairpin
probe
brightli
fluoresc
bound
target
probe
possess
stem
loop
structur
loop
contain
complementari
target
sequenc
stem
form
anneal
short
complementari
nucleotid
sequenc
arm
adjac
target
sequenc
fluorophor
coval
link
one
end
stem
sequenc
quencher
coval
link
end
free
solut
molecular
beacon
fluoresc
stem
structur
keep
fluorophor
close
quencher
fluoresc
energi
absorb
releas
heat
presenc
target
dna
howev
loop
sequenc
anneal
target
probetarget
hybrid
form
forc
stem
contain
fluorophor
quencher
apart
fluoresc
occur
molecular
beacon
better
suit
linear
probe
monitor
authent
amplicon
pcr
reaction
singl
nucleotid
mismatch
prevent
molecular
beacon
bind
target
light
taqman
molecular
beacon
detect
singl
nucleotid
chang
highli
suitabl
allel
discrimin
singl
multiplex
reaction
assay
combin
numer
probe
capabl
identifi
multipl
pathogen
effici
costeffect
approach
clinic
microbiolog
lab
greatli
expand
capac
pathogen
survey
multiplex
assay
requir
probe
repres
differ
target
reliabl
resolv
reaction
tube
well
typic
differ
probe
label
rang
fluorophor
uniqu
emiss
spectra
discern
discret
optic
dispers
onto
array
detect
deal
fluorophor
spectral
properti
probetarget
hybrid
must
significantli
differ
unbound
probe
permit
unambigu
probe
identif
lightcyclertm
taqmantm
molecular
beacon
probe
suitabl
multiplex
assay
abil
multiplex
pcr
probe
color
melt
temperatur
greatli
expand
power
realtim
analysi
novel
label
techniqu
evolv
quickli
allow
target
simultan
evalu
singl
reaction
exampl
masstag
pcr
use
detect
viral
hemorrhag
fever
multiplex
assay
microbi
gene
target
code
librari
distinct
mass
tag
nucleic
acid
amplifi
multiplex
pcr
use
primer
label
photocleav
link
differ
molecular
weight
tag
separ
amplif
product
unincorpor
primer
releas
mass
tag
amplicon
uv
irradi
tag
ident
analyz
mass
spectrometri
number
target
sequenc
propos
identif
pathogen
like
use
bioterrorist
event
target
specif
singl
speci
subspeci
toxin
virul
factor
tabl
target
use
gener
ribosom
rna
rrna
gene
heat
shock
gene
gene
contain
highli
conserv
dna
sequenc
usual
requir
function
interspac
variabl
region
wide
util
speciesspecif
genet
assay
ribosom
gene
fungi
bacteria
conserv
sequenc
ideal
univers
primer
target
contain
variabl
sequenc
region
speciesspecif
present
high
copynumb
tandem
repeat
gene
smallsubunit
ribosom
rna
slike
especi
use
evolutionari
studi
distant
phylogenet
relationship
remain
quit
stabl
evolut
organ
slike
ribosom
gene
amplifi
total
dna
isol
essenti
organ
use
singl
set
primer
recogn
conserv
region
gene
dna
rna
wide
varieti
organ
amplifi
use
singl
set
univers
pcr
primer
bind
conserv
region
gene
speci
determin
may
perform
analyz
speciesspecif
sequenc
contain
region
within
result
amplicon
advantag
type
target
specif
target
detect
sampl
heavili
contamin
nonpathogen
bacteria
also
make
possibl
detect
virul
factor
insert
normal
innocu
bacteria
univers
target
amplif
approach
advantag
easili
multiplex
singl
set
primer
serv
amplifi
multipl
speci
permit
develop
gener
diagnost
assay
two
approach
use
develop
target
viral
detect
assay
although
univers
primer
gener
restrict
bacteria
fungi
specif
famili
virus
sampl
process
develop
integr
compon
success
diagnost
program
bioterrorist
event
depend
size
durat
public
health
lab
may
need
process
ten
thousand
specimen
rapid
nucleic
acid
extract
clinic
environment
sampl
critic
downstream
molecular
evalu
extract
genet
materi
must
autom
ultrasensit
high
throughput
capabl
process
organ
larg
sampl
popul
detect
nucleic
acid
infect
microorgan
virus
whole
blood
tissu
respiratori
secret
urin
bodi
fluid
influenc
numer
factor
sampl
prepar
depend
type
biolog
materi
vari
consist
viscos
highli
viscou
sampl
mucou
difficult
handl
process
bacteri
fungal
spore
encas
heat
larg
chemic
resist
shell
make
isol
nucleic
acid
troublesom
new
cell
spore
disrupt
techniqu
involv
mechan
chemic
enzymat
thermal
treatment
improv
extract
effici
markedli
procedur
suitabl
robot
high
throughput
process
possibl
liquid
biolog
sampl
centrifug
concentr
bacteria
spore
fungi
prior
nucleic
acid
extract
increas
puriti
effici
anticoagul
edta
heparin
citrat
limit
product
format
interf
pcr
larg
excess
free
genom
dna
differenti
surfacebas
bind
procedur
develop
purifi
concentr
target
dna
away
genom
dna
hostassoci
inhibitor
improv
sensit
magnet
bead
technolog
ideal
choic
nucleic
acid
isol
purif
greater
affin
nucleic
acid
convent
method
reduc
risk
sampl
cross
contamin
found
extract
method
elimin
centrifug
manual
step
extract
purif
process
magnet
bead
base
nucleic
acid
extract
perform
micro
volum
sampl
complet
autom
high
throughput
rapidli
isol
purifi
nucleic
acid
h
commerci
system
magna
pure
lctm
kingfishertm
nuclisen
readili
avail
clinic
laboratori
extract
dna
rna
wide
rang
pathogen
bacteria
virus
fungi
present
clinic
sampl
standard
product
allow
highli
effici
target
captur
scalabl
wide
rang
nucleic
acid
level
system
benchtop
size
fulli
selfcontain
microfluid
system
sampl
extract
nucleic
acid
detect
cepheid
mida
ii
microfluid
dna
analysi
system
provid
rapid
onsit
test
bioterror
pathogen
environment
sampl
automat
process
biolog
sampl
extract
nucleic
acid
prepar
test
system
transfer
extract
nucleic
acid
pcr
reagent
realtim
thermal
cycler
eight
independ
programm
reaction
site
critic
process
analysi
perform
close
microfluid
system
includ
postanalysi
cleanup
decontamin
techniqu
allow
continu
autom
oper
extend
time
assay
time
less
min
pathogen
detect
one
primari
outcom
rapid
diagnost
develop
facilit
therapeut
intervent
detect
infecti
agent
earli
infect
goal
requir
new
molecular
detect
techniqu
optim
sensit
specif
valid
import
consider
abl
quantit
compar
cultur
antigenbas
detect
individu
molecular
probe
molecular
diagnost
approach
valid
new
diagnost
tool
refin
use
assess
earlier
predictor
diseas
elev
temperatur
measur
immunolog
respons
ideal
valid
new
diagnost
occur
statist
demonstr
equival
superior
convent
detect
methodolog
clinic
sampl
typic
valid
best
determin
clinic
specimen
obtain
patient
endem
area
diseas
select
agent
human
infect
rare
occur
remot
region
outsid
usa
make
valid
human
popul
impract
partial
solut
use
welldevelop
anim
infect
model
optim
provid
initi
valid
new
diagnost
tool
primari
advantag
anim
infect
model
infect
progress
diseas
precis
defin
goal
optim
studi
anim
achiev
highest
possibl
level
detect
maintain
fidel
identif
absenc
fals
posit
rapid
advanc
genom
sequenc
bacteria
virus
past
year
made
possibl
consid
sequenc
genom
pathogen
affect
human
well
crop
livestock
upon
live
depend
chembio
nonprolifer
program
us
depart
energi
began
largescal
effort
pathogen
detect
earli
effort
provid
biosecur
winter
olymp
game
salt
lake
citi
utah
molecular
assay
develop
lawrenc
livermor
nation
lab
like
bioterrorist
agent
util
whole
genom
comparison
method
recogn
uniqu
region
pathogen
genom
suitabl
identif
geneticbas
rapid
assay
develop
major
threat
list
agent
adequ
genom
sequenc
avail
well
pathogen
request
variou
govern
agenc
assay
valid
cdc
use
winter
olymp
program
continu
add
new
pathogen
expand
divers
detect
platform
olymp
air
monitor
util
monitor
station
area
center
salt
lake
citi
filter
remov
h
basi
test
genom
fragment
bioterror
pathogen
screen
period
sampl
collect
citi
airport
posit
initi
screen
airport
alert
regard
potenti
evacu
confirmatori
test
neg
caus
fals
posit
test
result
specifi
us
depart
homeland
secur
expand
program
biowatch
multic
initi
program
earli
warn
system
one
report
posit
assay
incid
origin
houston
texa
air
filter
detect
genom
evid
f
tularensi
caus
tularemia
air
monitor
filter
octob
subsequ
assay
neg
sourc
posit
test
clear
tularemia
endem
state
millionyear
system
expand
citi
late
yet
critic
unabl
detect
small
releas
pathogen
juli
unit
state
postal
servic
employ
mail
process
center
high
throughput
bioagent
detect
system
bd
develop
northrop
grumman
compani
autom
system
sampl
air
critic
point
around
mail
sort
machin
air
drawn
spin
membran
chemic
enhanc
water
remov
contamin
dna
sampl
pcr
probe
methodolog
develop
cepheid
inc
system
fulli
autom
run
complet
min
biolog
agent
detect
system
alert
gener
shut
oper
bd
develop
initi
anthrax
expand
includ
pathogen
adapt
toxin
well
scienc
applic
intern
corpor
develop
biosensor
combin
advanc
genom
signal
process
techniqu
identifi
known
newli
emerg
bioengin
pathogen
includ
virus
bacteria
fungi
protozoa
known
tiger
triangul
identif
genet
evalu
risk
biosensor
use
mass
spectrometri
determin
mass
core
genet
materi
select
extract
pathogen
tiger
use
special
algorithm
read
pathogen
genet
signatur
sensor
check
pathogen
mass
mass
known
pathogen
databas
system
differ
antibodybas
biosensor
detect
unknown
bioengin
pathogen
antibodybas
microarray
fabric
wide
rang
pathogen
toxinspecif
antibodi
rapidli
emerg
approach
hold
great
promis
diseas
detect
proteom
similarli
mass
spectrometrybas
proteom
emerg
import
tool
use
studi
proteinprotein
interact
small
proteomewid
scale
gener
quantit
protein
profil
divers
speci
abil
mass
spectrometri
identifi
accur
thousand
protein
complex
sampl
continu
improv
impact
biolog
medicin
direct
nucleic
acid
detect
method
may
suffici
sensit
detect
pathogen
either
present
low
level
bodi
fluid
tissu
promis
approach
assess
hostpathogen
interact
earli
stage
infect
develop
signatur
host
immunolog
respons
pcr
antigen
captur
assay
requir
presenc
caus
agent
number
recent
studi
suggest
pathogenspecif
differ
innat
host
immun
respons
differ
detect
transcript
profil
dna
microarray
approach
molecular
immunolog
signatur
bar
codelik
respons
would
gener
correspond
given
pathogen
conclus
rapid
advanc
diagnost
technolog
facilit
realtim
multiplex
detect
wide
rang
human
pathogen
rang
platform
avail
clinic
public
health
laboratori
advanc
chipbas
detect
system
larg
confin
academia
final
miniatur
technolog
rise
trend
like
mani
diagnost
platform
also
emerg
deploy
handheld
pointofcar
devic
suitabl
rapid
detect
agent
bioterror
natur
occur
epidem
diseas
